Well Sharmon,,as this is a support forum(and one of the better ones I may add) I am not prepared to go back and forth with you on this anymore
Just a couple of things before I close out on this thread
I am very familiar with PHO (Public Health Ontario). When you stated you contacted OHP I thought you were possibly meaning OHIP ,however it was just that you transposed the letters.
Your last post is incorrect at a number of points You say 1) the lab does not store results <15iu/ml .
2) That Ontario seems to think that <15iu/ml isn't infected anymore and 3) that they do not report these results to the ordering Dr.
This is the PHO form to Doctors on what they provide:
HCV RNA Result Interpretation Comments
Detected Hepatitis C RNA
detected, <15 IU/mL
The result for HCV RNA is below the linear range of the
assay, and thus the exact value cannot be calculated
Not detected No detectable
Hepatitis C RNA
Refer to comments on laboratory report if follow-up
testing is required
2. Hepatitis C Genotype
Clinical Utility
Genotyping of HCV is useful in evaluating the likelihood of response to currently available antiviral therapy.
One of the reasons I have responded here Sharmon is to possibly be of some help to you with advice as I have been involved with the medical system for approx. 60yrs in Ontario,20 of those involved with testing my HCV in various forms (RNA's ,viral loads done while treating,4 of which were done in the last 3 months ,resistance testing and more ) All done by PHO and results deciminated in a timely fashion.
The other reason I am responding is because I imagine there are a number of folks on this forum from Canada(Ontario in particular) thinking of treating and they should know that their testing will be done in a timely fashion and sent to their doctor when ordered.
I honestly don't know what the problem is with your particular tests however others should know reading your posts that it is certainly not the norm in Ontario
Again.. I wish you the best in this.
S
Diagnosed: 2001 GT1a , HCV since mid-70's.
Biopsy 2010 F1
Fibroscan and Fibrosure 2018 F2
Treated in trial 2010 with Dac/Peg/ Riba and Relapsed.
Resistance test 2017. Have Ns5a Rav Q30r/H58d enhanced from doing Dac.
Start Tx. Jan 18th/18 w/ Vosevi /Riba 12wks. plus 6 wks.Viekira Pak +Sof/Riba(From Dr Freeman @GP2U)
VL start: 1.6mill.ALT 125 AST 88
Wk. 4 Det @LLOQ <15.
VL Wk.8 UND Alt &Ast 22
Wk. 12 UND
EOT:UND
EOT+12 >>>UND (SVR12)! ALT11 AST13
Nov6/18 SVR 24!